Oragenics, Inc. (OGEN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oragenics, Inc. on April 15, 2024. The filing addresses Item 5.08 regarding Shareholder Director Nominations and the scheduling of the company's 2023 Annual Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly procedural and contains no financial performance data.
Material Changes
The primary material change reported is the advancement of the 2023 Annual Meeting of Shareholders. The meeting date has been set for July 15, 2024, which is more than 30 days prior to the anniversary of the 2022 Annual Meeting.
Guidance, Outlook, and Management Commentary
Management has established a new deadline for shareholder proposals intended for inclusion in the 2023 proxy statement. Proposals must be received by May 20, 2024. The record date, time, and location for the meeting will be detailed in the upcoming proxy statement. No financial guidance or risk factors were disclosed in this specific filing.
Key Facts for Investor Verification
- Annual Meeting Date: July 15, 2024.
- Proposal Deadline: May 20, 2024, for inclusion in the proxy statement.
- Submission Address: Oragenics, Inc., Attn: Corporate Secretary, 1990 Main Street, Suite 750, Sarasota, Florida 34236.
- Regulatory Basis: The change in meeting date triggers Rule 14a-5(f) under the Securities Exchange Act of 1934, necessitating this notice.